The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
Alkem’s domestic business grew 9.7 per cent versus the Indian pharmaceutical market growth of 8.5 per cent
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
Annual EBITDA margin expands by 170 basis points
Aarti Pharmalabs becomes 6th Indian Pharma/CDMO to earn SBTi approval for all 3 Scopes since 2022 demerger
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
PRX-PLUS has a unique product feature with its deep-impacting formula
Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
Prior to joining Neuland, Deshmukh held several key positions at Cipla
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
Subscribe To Our Newsletter & Stay Updated
